From: NEAL LANGERMAN <neal**At_Symbol_Here**CHEMICAL-SAFETY.COM>
Subject: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th
Date: Fri, 10 Apr 2020 13:53:21 -0700
Reply-To: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**PRINCETON.EDU>
Message-ID: CAOo07Zrr6QMsqd+zb3iAk+isBtHUhA47D5yuDbb6Le3rEUeVdw**At_Symbol_Here**mail.gmail.com
In-Reply-To <00e101d60f76$380704f0$a8150ed0$**At_Symbol_Here**bellsouth.net>


I point out, with no criticism intended or implied that the relevant epidemiology parameter is tests per unit population not total tests. The USA is way behind by that measure.
Further clinicians can correctly diagnose COVID 19 w/o testing. Broad-based testing is needed for reliable evidence - based policy decisions.
Stay healthy and stay safe.
Neal

Sent from Neal Langerman's NEXUS 6.
Standard client confidentiality terms apply.

On Fri, Apr 10, 2020, 13:25 Zack Mansdorf <mansdorfz**At_Symbol_Here**bellsouth.net> wrote:

Monna:

First, we actually have tested more people than any other country in the world. Some of the testing in some countries (such as China) had poor reliability. Antibodies normally indicate that you are over the infection if you are walking around versus being treated and I am not aware of any test for "shedding". Tests for having the infection would not make sense if you have no symptoms (it is not practical to test 320 million people). Having a negative test on Tuesday, means you do not have the virus on Tuesday. Maybe you get it Wednesday.

Zack

From: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**PRINCETON.EDU> On Behalf Of Monona Rossol
Sent: Friday, April 10, 2020 2:38 PM
To: DCHAS-L**At_Symbol_Here**PRINCETON.EDU
Subject: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th

Gee, how about we test people? There are tests for shedding, tests for anitbodies (doesn't mean you still aren't shedding) and tests for just plain having the virus. We see a lot more testing in other countries. You can't fix what you can't track. Monona

-----Original Message-----
To: DCHAS-L**At_Symbol_Here**PRINCETON.EDU
Sent: Fri, Apr 10, 2020 11:33 am
Subject: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th

While it is true that perhaps as much as 50% or those infected are asymptomatic, what else can be done as a screen in the absence of a readily available quick turn-around test for the virus or antibodies?

Temperature screening was more effective with SARS-1 since it looked like the asymptomatic were not infectious.

At least a temperature screen will identify _some_ of those infected. These days, the perfect cannot be the enemy of the "sort-of OK."

Peter Zavon, CIH
Penfield, NY

PZAVON**At_Symbol_Here**Rochester.rr.com

From: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**PRINCETON.EDU> On Behalf Of Monona Rossol
Sent: Thursday, April 9, 2020 10:04 PM
To: DCHAS-L**At_Symbol_Here**PRINCETON.EDU
Subject: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th

That sounds about right on the PPE, with the mask an N95 if possible. But the policy is flawed because the asymptomatic carriers will waltz through your test and into the building. Monona

-----Original Message-----
From: Michael Schaffer <MichaelS**At_Symbol_Here**PSYCHEMEDICS.COM>
To: DCHAS-L**At_Symbol_Here**PRINCETON.EDU
Sent: Thu, Apr 9, 2020 7:33 pm
Subject: Re: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th

QUESTION

WE ARE INSTITUTING A MANADATORY TEMPERATURE BE TAKEN OF EVERY PERSON ENTERING OUR BUILDING. THE QUESTION CAME UP AFTER WE PURCHASED THE TEMORAL THERMOMETERS, WHAT SHOULD THE PPE BE FOR THIS PERSON? OBVIOUSLY THEY CANT BE 6 FEET APART.

OUR SHORT ANSWERT WAS LAB COAT, MASK, FACE SHIELD AND GLOVES.

ANY OTHER RECOMMENDATIONS FOR NON MEDICAL FACILITIES?

Michael I. Schaffer, Ph.D., F.A.B.F.T., NRCC-TC

VP Laboratory Operations

Psychemedics Corporation

5832 Uplander Way

Culver City, CA 90230

310-216-7776 (phone)

310-216-6662 (Fax)

(800) 522-7424 (toll free) Extension 140

*** CONFIDENTIALITY NOTICE ***

THIS ELECTRONIC MAIL TRANSMISSION AND THE DOCUMENTS ACCOMPANYING IT CONTAIN INFORMATION BEING SENT BY PSYCHEMEDICS CORPORATION AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL AND/OR EXEMPT FROM DISCLOSURE. The information is intended only for the use of the person(s) named above. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or the taking of any action in reliance on the contents of this information is strictly prohibited. If you have received this transmission in error, please immediately notify us by telephone at (800) 522-7424 and delete/destroy all copies. Your receipt of this message is not intended to waive confidentiality or any privilege. The above name and title are not intended to constitute any form of signature.

From: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**PRINCETON.EDU> On Behalf Of Harry Elston
Sent: Thursday, April 9, 2020 11:33 AM
To: DCHAS-L**At_Symbol_Here**PRINCETON.EDU
Subject: [DCHAS-L] Ask Dr. Safety: Recovery and Contingency - A Virtual Symposium Wednesday Evening April 15th

This Message Originated Outside the Company

Good afternoon, DCHAS!

Last night, Neal and I hosted a version of "Ask Dr. Safety" and it was a hit - so much so that people wanted more and they told us what they wanted to talk about: Recovery and Contingency planning for post-COVID-19 activities.

So, Wednesday, April 15th, 9PM Eastern (8PM Central, 7PM Mountain, 6PM Pacific) we will be having a second round of Ask Dr. Safety on Google Meet.

Email me at (harry**At_Symbol_Here**midwestchemsafety.com) OFF LIST for log-on information. Google Meet limits participants to 250

Hope to see you there!

Harry

++++++++++++

Harry J. Elston, Ph.D., CIH, PMP

Principal, Midwest Chemical Safety

Standard confidentiality terms apply to this e-mail message.

--- For more information about the DCHAS-L e-mail list, contact the Divisional membership chair at membership**At_Symbol_Here**dchas.org Follow us on Twitter **At_Symbol_Here**acsdchas

--- For more information about the DCHAS-L e-mail list, contact the Divisional membership chair at membership**At_Symbol_Here**dchas.org Follow us on Twitter **At_Symbol_Here**acsdchas

--- For more information about the DCHAS-L e-mail list, contact the Divisional membership chair at membership**At_Symbol_Here**dchas.org Follow us on Twitter **At_Symbol_Here**acsdchas

--- For more information about the DCHAS-L e-mail list, contact the Divisional membership chair at membership**At_Symbol_Here**dchas.org Follow us on Twitter **At_Symbol_Here**acsdchas

--- For more information about the DCHAS-L e-mail list, contact the Divisional membership chair at membership**At_Symbol_Here**dchas.org Follow us on Twitter **At_Symbol_Here**acsdchas

--- For more information about the DCHAS-L e-mail list, contact the Divisional membership chair at membership**At_Symbol_Here**dchas.org Follow us on Twitter **At_Symbol_Here**acsdchas
--- For more information about the DCHAS-L e-mail list, contact the Divisional membership chair at membership**At_Symbol_Here**dchas.org Follow us on Twitter **At_Symbol_Here**acsdchas

Previous post   |  Top of Page   |   Next post



The content of this page reflects the personal opinion(s) of the author(s) only, not the American Chemical Society, ILPI, Safety Emporium, or any other party. Use of any information on this page is at the reader's own risk. Unauthorized reproduction of these materials is prohibited. Send questions/comments about the archive to secretary@dchas.org.
The maintenance and hosting of the DCHAS-L archive is provided through the generous support of Safety Emporium.